EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset

Cassandra M Joynes, Murat Bilgel, Yang An, Abhay R Moghekar, Nicholas J Ashton, Przemysław R Kac, Thomas K Karikari, Kaj Blennow, Henrik Zetterberg, Madhav Thambisetty, Luigi Ferrucci, Susan M Resnick und 1 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.14405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Cassandra M Joynes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Brain, Amyloid beta-Peptides, Cognitive Dysfunction, Alzheimer Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AD Strategic Fund and the Alzheimer's Association, NIA NIH HHS, Familjen Rönströms Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The factors that influence the progression of Alzheimer's disease (AD) after individuals become amyloid‐positive are poorly understood. This study examines how sex influences the longitudinal trajectories of plasma AD and neurodegenerative biomarkers in the years following a person's estimated onset of amyloid‐β. METHODS Linear mixed‐effects modeling investigated overall and sex‐specific longitudinal trajectories of plasma biomarkers, brain volumes, and cognition relative to the estimated age of amyloid onset in a cohort of 78 amyloid‐positive Baltimore Longitudinal Study of Aging (BLSA) participants ( n = 45 male; follow‐up time: 6.8 years [SD 3.31]). Amyloid status was ascertained with 11 C‐Pittsburgh compound B (PiB) PET imaging. RESULTS After amyloid onset, men displayed steeper increases in pTau181, pTau231, and neurofilament light (NfL) compared to women. In this same period, men demonstrated steeper declines in brain volume and cognitive performance. DISCUSSION These findings suggest that sex influences the trajectory of AD pathology, neuronal injury, and symptom progression after individuals become amyloid‐positive. Highlights Steeper rates of increase in pTau and GFAP among amyloid‐positive individuals. After amyloid onset, steeper increases in pTau and NfL concentrations in men than in women. Steeper declines in brain volume and cognition in men corroborate biomarker results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainAmyloid beta-PeptidesCognitive DysfunctionAlzheimer DiseaseSex CharacteristicsHumansMaleFemaleBiomarkersAtrophyPositron-Emission TomographyAgedLongitudinal Studiestau ProteinsDisease ProgressionAged, 80 and overNeurofilament ProteinsAniline CompoundsThiazoles

Stichwörter der Autor:innen

Alzheimer's diseasebrain volume losscognitive declinelongitudinal studyplasma biomarkerssex differences

Substanzen

BiomarkersAmyloid beta-Peptidestau Proteins2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleNeurofilament ProteinsAniline CompoundsThiazoles

Autor:innen und Institutionen

  • Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
  • NIHR Biomedical Research Centre for Mental Health and Biomedical Research, Unit for Dementia at South London and Maudsley, NHS Foundation, London, UK.
  • Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.

Förderung

  • AD Strategic Fund and the Alzheimer's Association
  • NIA NIH HHS
  • Familjen Rönströms Stiftelse
  • Swedish Research Council
  • Alzheimer Drug Discovery Foundation
  • The Erling-Persson Family Foundation
  • The Bluefield Project
  • European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement

Zitieren

APA

Joynes, C. M., Bilgel, M., An, Y., Moghekar, A. R., Ashton, N. J., Kac, P. R., Karikari, T. K., Blennow, K., Zetterberg, H., Thambisetty, M., Ferrucci, L., Resnick, S. M., & Walker, K. A. (2025). Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14405

Vancouver

Joynes CM, Bilgel M, An Y, Moghekar AR, Ashton NJ, Kac PR, et al. Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14405

BibTeX
@article{Joynes2025,
  author = {Joynes, Cassandra M and Bilgel, Murat and An, Yang and Moghekar, Abhay R and Ashton, Nicholas J and Kac, Przemysław R and Karikari, Thomas K and Blennow, Kaj and Zetterberg, Henrik and Thambisetty, Madhav and Ferrucci, Luigi and Resnick, Susan M and Walker, Keenan A},
  title = {Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.14405}
}
Kostenlos starten →